未登录

Y

Yongxing Zhao

Zhengzhou University

H指数:24

被引数:2,223

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Augmenting Antioxidant Enzyme-Like Activity and Hydrogen Evolution of MoS2 @ Bi2S3 Heterojunction via Ultrasound-Evoked Piezoelectricity for Anti-Inflammation

通过超声诱发的压电效应增强MoS2@Bi2S3异质结的抗氧化酶样活性和氢气进化以实现抗炎效果

IF12.1

2025-05-230

PRE

PtCu nanozyme integrating single atom Pt and Pt subnanoclusters for the sustained treatment of cutaneous melanoma

PtCu纳米酶集成单原子Pt和Pt亚纳米簇，用于皮肤黑色素瘤的持续治疗

Chinese Chemical Letters

IF8.9

2025-03-310

PRE

Biomimetic Liposome Coloaded ES-Cu and PFK15 Amplify Cuproptosis through Inhibition of Glycolysis in Fibroblast-Like Synoviocytes for Rheumatoid Arthritis Therapy

ACS Applied Materials & Interfaces

IF0

2025-01-010

PRE

Discovery of Cyclic Peptide Inhibitors Targeted on TNFα-TNFR1 from Computational Design and Bioactivity Verification

IF4.6

2024-10-311

OAAI

Boosting Tumor Apoptosis and Ferroptosis with Multienzyme Mimetic Au Single-Atom Nanozymes Engaged in Cascade Catalysis

参与级联催化的多酶模拟Au单原子纳米酶促进肿瘤凋亡和铁死亡

ADVANCED FUNCTIONAL MATERIALS

IF19

2024-10-190

PRE

Targeted delivery of NO donor and ROS scavenger for synergistic treatment of rheumatoid arthritis

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2024-05-011

OAAI

Dual-targeting inhibition of TNFR1 for alleviating rheumatoid arthritis by a novel composite nucleic acid nanodrug

international journal of pharmaceutics

IF6.4

2023-12-015

OAAI

Targeting Tumor Necrosis Factor Receptor 1 with Selected Aptamers for Anti-Inflammatory Activity

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2023-02-227

PRE

Stimulus-responsive and dual-target DNA nanodrugs for rheumatoid arthritis treatment

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2023-02-019

PRE

Catalytic DNA-Assisted Mass Production of Arbitrary Single-Stranded DNA

催化DNA辅助大规模生产任意单链DNA

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2022-12-227

PRE

PBA functionalized single-atom Fe for efficient therapy of multidrug-resistant bacterial infections

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2022-11-0110

PRE

Dual-Drug Loaded Separable Microneedles for Efficient Rheumatoid Arthritis Therapy

用于有效治疗类风湿性关节炎的双药可分离微针

IF5.5

2022-07-2114

OAAI

Protein DEK and DTA Aptamers: Insight Into the Interaction Mechanisms and the Computational Aptamer Design

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2022-07-192

OAAI

Dual isolated bimetal single-atom catalysts for tumor ROS cycle and parallel catalytic therapy

双分离双金属单原子催化剂用于肿瘤ROS循环及平行催化治疗

IF10.9

2022-06-0146

PRE

Co-delivery of triamcinolone acetonide and verapamil for synergistic treatment of hypertrophic scars via carboxymethyl chitosan and Bletilla striata polysaccharide-based microneedles

CARBOHYDRATE POLYMERS

IF12.5

2022-05-0142

PRE

RETRACTION: Low density lipoprotein receptor targeted doxorubicin/DNA-Gold Nanorods as a chemo- and thermo-dual therapy for prostate cancer (Retraction of Vol 513, Pg 376, 2016)

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2022-03-010

PRE

Novel approaches of the nanotechnology-based drug delivery systems for knee joint injuries: A review

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2021-10-0113

PREAI

Which is Better for Nanomedicines: Nanocatalysts or Single-Atom Catalysts?

ADVANCED HEALTHCARE MATERIALS

IF9.6

2020-12-1617

PREAI

Selective inhibition of Tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases

CYTOKINE & GROWTH FACTOR REVIEWS

IF11.8

2020-10-0139

PREAI

Hyaluronic acid and antimicrobial peptide-modified gold/silver hybrid nanocages to combat bacterial multidrug resistance

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2020-08-0118

PREAI